Millennium Management

Millennium Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Millennium Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$1.05M	–	6334
2025 Q4	$1.05M	Buy	+50,000	New	+$872K	﹤0.01%	4454
2023 Q4	–	Sell	-260,000	Closed	-$3.78M	–	6503
2023 Q3	$3.78M	Buy	+260,000	New	+$4.92M	﹤0.01%	2978
2020 Q1	–	Sell	-100,000	Closed	-$878K	–	4431
2019 Q4	$878K	Sell	100,000 -100,000	-50%	-$734K	﹤0.01%	3063
2019 Q3	$1.49M	Buy	+200,000	New	+$1.82M	﹤0.01%	2630
2019 Q1	–	Sell	-300,000	Closed	-$1.33M	–	4302
2018 Q4	$1.33M	Sell	300,000 -14,900	-5%	-$81.7K	﹤0.01%	2441
2018 Q3	$2.54M	Buy	+314,900	New	+$2.24M	﹤0.01%	2270

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return